Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Protein tyrosine kinase inhibitors claimed by Pfizer for hyperproliferative disorders

July 16, 1998

ADIR discloses cytotoxic anthracene derivatives for leukemia and solid tumors

July 16, 1998

Vical and NCI initiate melanoma DNA vaccine trial

July 16, 1998

Phase I trial reports efficacy of chimeric MAb CH-14.18 in neuroblastoma

July 16, 1998

Indolocarbazoles for prostate disorders jointly developed by Cephalon and Kyowa Hakko

July 15, 1998

Fast track designation granted for FGN-1 in APC

July 15, 1998

Potent, broad-spectrum antitumor arylsulfonylimidazolidinone selected by Dong Wha

July 14, 1998

Spotlight on estrone sulfatase inhibitors for treatment of breast cancer

July 14, 1998

Vitamin D analogue EB-1089 acts via effects on IGF-I

July 14, 1998

IL-15 potentiates antitumor activity of 5-FU/leucovorin in colorectal cancer

July 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...